2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Immunotherapy: new trials by email Literature Review of Immunotherapy trials Research Report on Immunotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer Oxaliplatin, Tegafur-Gimeracil-Oteracil, Sintilimab - Stomach Neoplasms, Esophagogastric Junction Disorder | Phase 2 | Terminated | Fudan University | 6 | 2021-09-28 | 2025-06-18 |
| Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy Dexamthasone - Non-Small Cell Lung Cancer, Immunotherapy | Phase 1 / Phase 2 | Terminated | VA Office of Research and Development | 2 | 2021-07-07 | 2024-06-14 |
Adenocarcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Stomach Neoplasms (1)
Neoplasms (2) · Neoplasms by Site (2) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1)
Oxaliplatin (1) · sintilimab (1) · tegafur-gimeracil-oteracil (1)
Fudan University (1) · VA Office of Research and Development (1)
China (1) · United States (1)